Company Tsubota Laboratory Incorporated

Equities

4890

JP3535700003

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-16 EDT			5-day change	1st Jan Change
384 ^JPY	+2.40%		+8.78%	+14.63%

2022	Certain Common Stock of Tsubota Laboratory Incorporated are subject to a Lock-Up Agreement Ending on 19-DEC-2022.	CI
2022	Certain Common Stock of Tsubota Laboratory Incorporated are subject to a Lock-Up Agreement Ending on 20-SEP-2022.	CI

Tsubota Laboratory Inc is a Japan-based company mainly engaged in the research and development of new treatments for myopia, dry eye, and presbyopia. The Company operates with a B2B business model. The model generates revenue from lump-sum payments under joint research and development agreements and licensing agreements with partner companies, milestone payments, and royalties under post-commercialization (post-launch) loyalty agreements and creates new value by investing the profits in the new research. The Company is also engaged in the research and development of products for adults that treat depression and dementia, improve sleep and increase concentration.

Number of employees: 10

JPY in Million	2022	Weight	2023	Weight	Delta
Myopia Area 94.2 %	422	65.9 %	900	94.2 %	+112.93%
Brain Region 4.0 %	60	9.4 %	38	4.0 %	-36.17%
Others 1.3 %	21	3.3 %	12	1.3 %	-43.40%
Dry Eye Region 0.3 %	110	17.1 %	3	0.3 %	-97.52%
Presbyopia Area 0.2 %	27	4.3 %	2	0.2 %	-92.79%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 68.4 %	641	100.0 %	653	68.4 %	+1.89%
France 30.0 %	-	-	287	30.0 %	-
North America 1.6 %	-	-	15	1.6 %	-

Managers	Title	Age	Since
Kazuo Tsubota FOU	Founder	69	12-05-27
Takanari Shimizu ADM	Chief Administrative Officer	-	-
Shinichiro Kondo CTO	Chief Tech/Sci/R&D Officer	55	15-01-31
Shintaro Yamada BRD	Director/Board Member	51	12-04-30

Members of the board	Title	Age	Since
Shinichi Koizumi BRD	Director/Board Member	68	20-05-31
Kazuo Tsubota FOU	Founder	69	12-05-27
Shintaro Yamada BRD	Director/Board Member	51	12-04-30
Shinichiro Kondo CTO	Chief Tech/Sci/R&D Officer	55	15-01-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	25,577,500	6,714,800 ( 26.25 %)	0	26.25 %

Name	Equities	%	Valuation
Kazuo Tsubota 62.57 %	15,991,800	62.57 %	36 M ¥
Isao Otaka 7.199 %	1,840,000	7.199 %	4 M ¥
Tanaka Family 0.9782 %	250,000	0.9782 %	565 565 ¥
ROHTO PHARMACEUTICAL CO.,LTD. 0.8608 %	220,000	0.8608 %	497 697 ¥
JINS HOLDINGS INC. 0.8608 %	220,000	0.8608 %	497 697 ¥
Yutaka Hara 0.8600 %	219,800	0.8600 %	497 245 ¥
Temur Partners Co. Ltd. 0.6260 %	160,000	0.6260 %	361 962 ¥
Shintaro Yamada 0.4954 %	126,600	0.4954 %	286 402 ¥
Eri Kubota 0.4304 %	110,000	0.4304 %	248 849 ¥
Fivestar Asset Management Co. Ltd. 0.0548 %	14,000	0.0548 %	31 672 ¥

Tsubota Laboratory, Inc.

Toshin Shinanomachi-ekimae Bldg. 304 34 Shinanomachi

160-0016, Tokyo

http://tsubota-lab.com

address Tsubota Laboratory Incorporated(4890)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
TSUBOTA LABORATORY INCORPORATED	+14.63%	61.95M
MODERNA, INC.	+33.37%	49.46B
IQVIA HOLDINGS INC.	+1.55%	42.58B
LONZA GROUP AG	+49.11%	42.49B
CELLTRION, INC.	-4.22%	29.09B
ICON PUBLIC LIMITED COMPANY	+11.57%	26.61B
ALNYLAM PHARMACEUTICALS, INC.	-21.00%	18.64B
BIO-TECHNE CORPORATION	+7.36%	13.16B
MEDPACE HOLDINGS, INC.	+28.30%	12.55B
UNITED THERAPEUTICS CORPORATION	+23.80%	12.1B

Other Biotechnology & Medical Research